← All organizations
Highest phase reached
Phase 4
First clinical trial
Jul 31, 2020Last known activity
Jun 1, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (10 distinct, 6 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 2 (7 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (14)
- NCT06462248CollaboratorPhase 2Jun 1, 2024
- NCT06866873Sponsor investigatorN/AMay 1, 2024
- NCT06866873Lead sponsorN/AMay 1, 2024
- NCT06034535Lead sponsorPhase 2Sep 1, 2023
- NCT06034535Overall official - principal investigatorPhase 2Sep 1, 2023
- NCT06034535Reponsible party - principal investigatorPhase 2Sep 1, 2023
- NCT04543968Lead sponsorN/AJan 31, 2022
- NCT04543968Reponsible party - principal investigatorN/AJan 31, 2022
- NCT04543968Overall official - principal investigatorN/AJan 31, 2022
- NCT05754684Lead sponsorPhase 2Jan 1, 2022
- NCT05754684Reponsible party - principal investigatorPhase 2Jan 1, 2022
- NCT05754684Overall official - principal investigatorPhase 2Jan 1, 2022
- NCT04475705Overall official - principal investigatorPhase 4Jul 31, 2020
- NCT04475705Lead sponsorPhase 4Jul 31, 2020
Details
- Last known activity
- Jun 1, 2024